Home › Funds › Point72 Asset Management › RLMD
Point72 Asset Management position in RLMD
RELMADA THERAPEUTICS INC · Health Care
Latest position (Q1 2026)504.82K sh
Reported value held$3.51M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 220.00K | $5.77M | New |
| Q4 2021 | 946.31K | $21.32M | Add |
| Q1 2022 | 1.31M | $35.42M | Add |
| Q2 2022 | 1.27M | $24.17M | Reduce |
| Q3 2022 | 907.19K | $33.58M | Reduce |
| Q2 2023 | 4.70K | $11.57K | New |
| Q4 2023 | 250.00K | $1.03M | New |
| Q4 2025 | 187.38K | $905.03K | New |
| Q1 2026 | 504.82K | $3.51M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLMD
- Janus Henderson Group 11.06M sh · $76.89M · Q1 2026
- BlackRock Inc 7.43M sh · $51.39M · Q2 2026
- Geode Capital Management 2.49M sh · $17.25M · Q2 2026
- Millennium Management 2.36M sh · $16.34M · Q2 2026
- Marshall Wace 2.25M sh · $15.55M · Q2 2026
- Balyasny Asset Management 1.52M sh · $10.52M · Q2 2026
- Citadel Advisors 1.17M sh · $8.10M · Q2 2026
- Vanguard Group 1.20M sh · $5.81M · Q4 2025
- Bank of America Corp 812.06K sh · $5.62M · Q2 2026
- Northern Trust Corp 786.26K sh · $5.44M · Q2 2026
- Goldman Sachs Group 767.62K sh · $5.31M · Q2 2026
- Deutsche Bank AG 318.90K sh · $2.21M · Q2 2026